Therapeutic Drug Monitoring Market Size 2018, Global Industry Analysis,Share, Trends, Status and Future Forecast 2020

The Market Research on Therapeutic Drug Monitoring, By Considering useful aspects like; Application, End Users- Global Future Forecast till 2020, published by MarketsandMarkets™, the report studies the global Therapeutic Drug Monitoring market over the forecast period to 2020. The market is projected to reach USD 2.55 Billion by 2020 at a CAGR of 7.4%.

The study estimates the Therapeutic Drug Monitoring market size for 2018 and projects its demand till 2020. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include research scientists, Therapeutic Drug Monitoring specialists, laboratory technicians, and R&D professionals of pharmaceutical and biotechnology companies and academic research institutes.

The market is broadly segmented by product, technology, class of drug, end user, and region. Based on product, the Therapeutic Drug Monitoring market is segmented into consumables and equipment. The equipment market is further segmented into immunoassay analyzers, proteomic equipment, and other equipment.

The consumables segment is expected to account for nearly two-thirds of the global market. The immunology analyzers segment is expected to be the fastest-growing segment in its equipment market. Comparatively low costs of immunology analyzers and their ease of use are the primary factors driving the market growth in this segment.

Based on technology, the therapeutic drug monitoring market is categorized into three segments namely, immunoassays, proteomic technologies and others. The immunoassays segment is expected to account for the largest share of its technology market in 2015. Factors such as relatively simple tests and requirement of minimal training to handle the immunoassay analyzers will drive the growth of this segment.

Based on class of drug, the market is segmented into antiepileptics, antibiotics, immunosuppressants, antiarrhythmic drugs, bronchodilators, psychoactive drugs, and other classes. The antiepileptics segment is estimated to account for the largest share in 2015. By end user, the market is divided into hospital labs, commercial/private labs, and other end users. The hospital labs segment is estimated to account for the largest share in 2015.

The Therapeutic Drug Monitoring market is fragmented with the presence of emerging players;

Major players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Danaher Corporation (U.S)…..Read More

Request a Sample Copy of “Therapeutic Drug Monitoring Market” Consist of tables and figures and in-depth TOC: https://www.marketsandmarkets.com/requestsample.asp?id=155350443

Therapeutic Drug Monitoring Market, by Product

Consumables
Equipment

Therapeutic Drug Monitoring Market, by Technology

· Proteomics Technologies

Therapeutic Drug Monitoring Market, by Class of Drug

· Antiepileptics

· Antibiotics

· Immunosuppressants

Therapeutic Drug Monitoring Market, by End User

Hospital Laboratories
Commercial/Private Laboratories

Therapeutic Drug Monitoring Market, by Region;

· North America (US, Canada)

· Europe (UK, Germany, Others)

· Asia

· Rest of the World

For any queries Speak to our Analyst:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=155350443

Major Key Points from Table of Content:

· Introduction

· Research Methodology

· Therapeutic Drug Monitoring Market, By Product

· Therapeutic Drug Monitoring Market, By Technology.

· Competitive Landscape

· Company Profiles

The Objectives Covered in This Research Report:

-To define, describe, and forecast the global Therapeutic Drug Monitoring market based on product, application, end user, and region
-To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities and industry-specific challenges)
-To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
-To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders.

Major Key Points from List of Tables:

· Global Therapeutic Drug Monitoring Market Size, By Product

· North America: Consumables Market Size, By Country

· CLIA in Market Size, By Region

· LC-MS in Market Size, By Region

· Global Antiepileptics Monitoring Market Size, By Region,

· North America: Antiarrhythmic Drugs Monitoring Market Size, By Country

· TDM Market Size, By End User

· Therapeutic Drug Monitoring Market Size, By Region

· U.S.: Therapeutic Drug Monitoring Market Size, By Product,

· Canada: Therapeutic Drug Monitoring Market Size for Proteomics, By Type……. Click To Read Full Toc

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownload.asp?id=155350443

Major Key Points from List of Figures:

· Antiepileptics to Witness the Highest Growth Rate in the Market for Class of Drug

· Rising Focus on Pharmacogenetic Testing is Driving Growth in the Therapeutic Drug Monitoring Market

· Immunoassay Analyzers to Dominate the Equipment Market

· North America is Expected to Account for the Largest Share of the CLIA in Therapeutic Drug Monitoring Market During the Forecast Period

· North America is Expected to Witness the Highest Growth in the Immunosuppressants Monitoring Market During the Forecast Period

· Geographic Revenue Mix of the Top Three Market Players

· Company Snapshot: Roche Diagnostics

· Company Snapshot: Agilent Technologies

About MarketsandMarkets™ -

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: [email protected]